Synthesis of methyl O-(2-O-methyl-β-d-galactopyranosyl)-(1 → 4)-O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-(1 → 3)- β-d-galactopyranoside and 4-nitrophenyl O-β-d-galactopyranosyl-(1 → 4)-O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-β-d-galactopyranoside

[1]  R. Jain,et al.  Synthesis of benzyl O-(2-O-methyl-β-d-galactopyranosyl)-(1→3)-2-acetamido-2-deoxy-β-d-glucopyranoside [benzyl 2′-O-methyllacto-N-bioside I], and its higher saccharide containing an O-(2-O-methyl-β-d-galactopyranosyl)-(1→3)-2-acetamido-2-deoxy-β-d-glucopyranosyl group as a potential substrate for (1→ , 1990 .

[2]  T. Asao,et al.  Cancer‐associated elevation of α(1 → 3)‐l‐fucosyltransferase activity in human serum , 1988 .

[3]  K. Matta,et al.  Synthetic Mucin Fragments: Methyl-3-O-(2-Acetamido-2-Deoxy-4-O- and 6-O-β-D-Galactopyranosyl-β-D-Glucopyranosyl)-β-D-Galactopyranoside and Methyl 3-O-(2-Acetamido-2-Deoxy-4-O- and 3-O-Methyl-β-D-Glucopyranosyl-3-D-Galactopyranoside , 1988 .

[4]  E. Giralt,et al.  Uteroglobin-like peptide cavities I. Synthesis of antiparallel and parallel dimers of bis-cysteine peptides , 1988 .

[5]  P. Stanley,et al.  The GDP-fucose:N-acetylglucosaminide 3-alpha-L-fucosyltransferases of LEC11 and LEC12 Chinese hamster ovary mutants exhibit novel specificities for glycolipid substrates. , 1987, The Journal of biological chemistry.

[6]  C. Piskorz,et al.  Synthesis of 2-acetamido-2-deoxy-4-O-(2-O-methyl-beta-D-galactopyranosyl)- D-glucopyranose (N-acetyl-2'-O-methyllactosamine). , 1987, Carbohydrate research.

[7]  S. Hakomori,et al.  1H-n.m.r. analysis of glycolipids possessing mono- and multi-meric X and Y haptens: characterization of two novel extended Y structures from human adenocarcinoma. , 1986, Carbohydrate research.

[8]  M. Piver,et al.  Elevated activities of blood group Le gene dependent alpha(1----3)-L-fucosyltransferase in human saliva of Lewis negative patients with epithelial ovarian cancer. , 1986, Cancer letters.

[9]  S. Yazawa,et al.  Elevated serum α(1 → 3)-l-fucosyltransferase activity with synthetic low molecular weight acceptor in human ovarian cancer , 1986 .

[10]  S. Yazawa,et al.  Use of N-acetyl-2'-O-methyllactosamine as a specific acceptor for the determination of alpha-L-(1----3)-fucosyltransferase in human serum. , 1986, Analytical biochemistry.

[11]  S. Hakomori,et al.  Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). , 1985, The Journal of biological chemistry.

[12]  S. Hakomori,et al.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. , 1985, Cancer research.

[13]  T. Feizi,et al.  Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems , 1985 .

[14]  M. Fukuda,et al.  Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. , 1985, Biochimica et biophysica acta.

[15]  K. Matta,et al.  Synthetic mucin fragments: 3-O-[2-acetamido-4,6-di-O-acetyl-2-deoxy-3-O -(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-b-D-glucopyranosyl] -2,4,6-tri-O-acetyl-a-D-galactopyranosyl bromide and p-nitrophenyl 3-O-(2-acetamido-2-deoxy-3-O-b-D-galactopyranosyl-b-D glucopyranosyl)-b-D-galactopyranoside. , 1984, Carbohydrate research.

[16]  S. Hakomori,et al.  Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. , 1984, The Journal of biological chemistry.

[17]  S. Hakomori,et al.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. , 1984, The Journal of biological chemistry.

[18]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.

[19]  K. Matta,et al.  Use of 3-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-d-glucopyranosyl)-2,4,6-tri-O-acetyl-α-d-galactopyranosyl bromide as a glycosyl donor: Synthesis of p-nitrophenyl 3-O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-β-d-galactopyranoside , 1983 .